BIO-key International
BKYI
10 hedge funds and large institutions have $169K invested in BIO-key International in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
4% less capital invested
Capital invested by funds: $176K → $169K (-$7.25K)
9% less funds holding
Funds holding: 11 → 10 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| 3 |
HF
HRT Financial
New York
|
-$4.71K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.52K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$692 |
BKYI Hedge Fund Activity: Q1 2023 in Review
10 of the 6,251 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q1 2023, worth a combined $169K — down 4.1% from $176K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BKYI and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, cutting an estimated $20.4K.
- 10 institutional investors held BIO-key International (BKYI) as of Q1 2023, down from 11 in Q4 2022.
- Funds reported $169K of BIO-key International stock for Q1 2023, down 4.1% quarter-over-quarter.
- 0 funds opened new BIO-key International positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest BIO-key International seller in Q1 2023 was Susquehanna International Group, an estimated $20.4K sold.
Based on aggregated 13F filings for Q1 2023.